生物标志物
计算生物学
肝细胞癌
生物标志物发现
清脆的
基因
遗传异质性
癌症
Cas9
医学
生物
癌症研究
遗传学
表型
蛋白质组学
作者
Zhipu Liu,Long Liu,Shutong Liu,Yuhao Ba,Anning Zuo,Hui Xu,Yuyuan Zhang,Senyan Wang,Libo Wang,Xinwei Han
摘要
ABSTRACT Background and Aims Hepatocellular carcinoma (HCC) is a malignant tumor with a poor prognosis and is characterized by severe intratumoral heterogeneity. Identifying key genomic features and more reliable classifications is helpful for clinical management. Methods Cancer essential genes (CEGs) were identified using genome‐scale CRISPR‐Cas9 and univariate Cox regression analyses. Based on gene expression, nonnegative matrix factorization (NMF) was used to generate distinct molecular subtypes. The nearest template prediction (NTP) algorithm was used to validate the accuracy and robust classifications among three independent cohorts, including GSE14520, GSE54236, and ICGC‐LIRI. Specifically, potential biomarkers were screened for clinical transformation based on their prognostic characteristics and biological function features. EdU, colony formation, and Transwell assays were utilized to confirm the effect of biomarkers in vitro. Results The C1 subtype had the worst prognosis and was characterized by advanced AJCC stages and high genomic instability. The NTP approach confirmed that the molecular subtypes were practical, robust, and reproducible. We further identified NDC80 as a gene specifically expressed in C1 subtype, indicative of prognosis solely for this subtype. Based on overrepresentation analysis (ORA), it was found that the biological function of NDC80 was mainly enriched in proliferation. In vitro cellular assays verified that promoted tumor growth and migration. Conclusions Our study identified three robust molecular subtypes and revealed tumor heterogeneity. Meanwhile, the potential biomarker NDC80 served as a characteristic gene of the C1 subtype, correlating with poor prognosis and promoting tumor growth and migration, providing new insights for prognostic treatment strategies in HCC.
科研通智能强力驱动
Strongly Powered by AbleSci AI